Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Alexandra Gonçalves , Carla Sousa , José Alberto de Agustín , et al Added: 3 years ago
Valvular disease is the most prevalent structural heart disease among adults and its burden is growing along with the increase in life expectancy.1 Mitral regurgitation (MR) is the second most frequent valvular disease, after aortic stenosis. Its natural history is very variable and highly dependent on the presence of symptoms. However, even in asymptomatic patients, the prognosis of severe MR is… View more
Author(s): Roy Arjoon , Ashley Brogan , Lissa Sugeng Added: 3 years ago
Cardiovascular medicine has undergone a momentous change over the past 2 decades with the development of percutaneous transcatheter interventions for structural heart disease. This field has the greatest growth in interventional cardiology for the foreseeable future.1–3 The number of patients with acquired valvular heart disease and adult congenital heart disease will only rise in the future as… View more
Author(s): Ahmad Younes , Guilherme Ferragut Attizzani , Ankur Kalra Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1 As… View more
Author(s): Ole De Backer Added: 4 years ago
Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) provides an update from theGALILEO-4D trial, discussing the comparison ofa Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves. What is the GALILEO-4D study and how is it related to the main GALILEO trial? What is the design of the study and what… View more
Author(s): Bijoy K Khandheria Added: 3 years ago
Cardiovascular ultrasound is an established imaging modality in the practice of cardiovascular disease (CVD), whether this is provided by a CV specialist or health professionals with training in internal medicine. Transthoracic imaging wherein the transducer is placed on the chest wall has some limitations. These include inadequate quality of images resulting in poor informationÔÇöapproximately 5… View more
Author(s): Bijoy K Khandheria Added: 3 years ago
Cardiovascular ultrasound is an established imaging modality in the practice of cardiovascular disease (CVD), whether this is provided by a CV specialist or health professionals with training in internal medicine. Transthoracic imaging wherein the transducer is placed on the chest wall has some limitations. These include inadequate quality of images resulting in poor informationÔÇöapproximately 5… View more